首页> 外文期刊>Multiple Sclerosis Journal ?C Experimental, Translational and Clinical >Chronic inflammatory demyelinating polyradiculoneuropathy occurring after autologous haematopoietic stem cell transplantation for multiple sclerosis:
【24h】

Chronic inflammatory demyelinating polyradiculoneuropathy occurring after autologous haematopoietic stem cell transplantation for multiple sclerosis:

机译:自体造血干细胞移植治疗多发性硬化后发生的慢性炎症性脱髓鞘性多发性神经根病:

获取原文
           

摘要

We describe the case of a man in his 40a??s with aggressive multiple sclerosis (MS) who received autologous haematopoietic stem cell transplantation (AHSCT) and subsequently developed probable, if not definite, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and haematological complications. Autoimmune conditions occurring as a side effect of allogenic transplantations are well known in the context of haematological malignancies, but only rarely reported for autologous transplantations. Our case demonstrates that although AHSCT may be effective for suppressing MS inflammatory activity, the profound changes to the immune repertoire may lead to other clinically relevant autoimmune phenomena. A careful benefit-risk evaluation should be conducted in all cases where AHSCT is considered.
机译:我们描述了一个40多岁的患有侵袭性多发性硬化症(MS)的人的案例,该人接受了自体造血干细胞移植(AHSCT),随后发展为(即使不是确定的)慢性炎性脱髓鞘性多发性神经根神经病(CIDP)和血液系统并发症。作为异体移植的副作用而发生的自身免疫疾病在血液系统恶性肿瘤的背景下是众所周知的,但很少报道自体移植。我们的案例表明,尽管AHSCT可能对抑制MS炎症活性有效,但免疫系统的深刻变化可能导致其他临床相关的自身免疫现象。在考虑AHSCT的所有情况下,都应进行仔细的利益风险评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号